FDG-PET guidance allows substantial chemoreduction in Hodgkin lymphoma

Bendamustine for indolent lymphoma reduces relapse after 10 years

Prevalence of homologous recombination deficiency among 53,000 tumour samples

Natural plant based balm antidote to severe nail toxicity during chemotherapy

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy

Hypogonadism following cisplatin treatment of testicular cancer

EADO conference highlights

Theory and application of electrochemotherapy

Molecular testing for targeted therapies

Essential regional control of skin cancers

Brain metastases: a role of conventional chemotherapy?

IMPAKT conference highlights